Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
-8,34%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
77,14%
Outlook 12/26
W
-24,14%
Margin of safety
T
9,42%
Analyst Price Target
H
UP
50-week EMA Trend
Company Info
EPS Growth 5Y
-38,10%
Revenue growth 5Y
23,93%
Price growth 5Y
38,40%
Market Cap
C$0,73 B
Long-Term Debt
C$0,05 B
Short Interest
26,37%
Quarterly earnings
05/07/2026
Dividend
C$0,00
Dividend Yield
0,00%
Industry
Country
ISIN Number
Knight Therapeutics Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
C$8,25
9.42%
Last Update: 04/24/2026
Analysts: 6
Highest Price Target C$11,00
Average Price Target C$8,25
Lowest Price Target C$6,15
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Knight Therapeutics
TSX:GUD
|
38,40% | 38,40% | 0,00% | -8,34% | 5/6 | 77,14% | -24,14% | 10,59% | UP |
